Abstract
Hepatic metastases represent a common site of dissemination for a number of primary malignancies, partly because of the dual blood supply, the large blood flow, and the receptive environment of the hepatic parenchyma. Primary gastrointestinal neoplasms are particularly prone to develop hepatic metastases. Most of what we have learned concerns the treatment of metastases of colorectal cancers, because these primary lesions are very common, usually can be removed widely along with regional lymphatic spread, and thus often give rise to resectable hepatic metastases that appear to be the only residual sites of growth.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288
Bismuth H (1982) Surgical anatomy and anatomical surgery of the liver. World J Surg 6:3–9
Adson MA (1987) Resection of liver metastases—when is it worthwhile? World J Surg 11:511–520
Foster JH (1978) Survival after liver resection for secondary tumors. Am J Surg 135:389–394
Logan SE, Meier SJ, Ramming KP, Morton DL, Longmire WP Jr (1982) Hepatic resection of metastases colorectal carcinoma: a ten year experience. Arch Surg 117:25–28
Kortz WJ, Meyers WC, Hanks JB et al. (1984) Hepatic resection for metastatic cancer. Ann Surg 199:182–186
Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 199:306–316
Butler J, Attiyeh FF, Daly JM (1986) Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 162:109–113
Cady B, Oberfield RA (1974) Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 127:220–227
Ekberg H (1986) Colorectal liver cancer, resection and regional chemotherapy. Thesis. Bulletin no. 61, Department of Surgery, Lund University, Lund, Sweden pp 1–62
Iwatsuki S, Byers W, Starzl TE (1983) Experience with 150 liver resections. Ann Surg 197:247–253
Kemeny N (1983) The systemic chemotherapy of hepatic metastases. Semin Oncol 10:148–158
Balch CM, Urist MM (1983) Vollständig implantierbare Infusions-pumpe. Eine neue Behandlungsmöglichkeit für ausgewählte Patienten mit Lebertumoren. Dtsch med Wochenschr 26:1008–1013
Ensminger W, Niederhuber J, Dakhil S, Thrall J, Wheeler R (1981) Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 65:393–400
Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E (1984) Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53:1336–1343
Barone RM, Byfield JE, Goldfarb PB, Frankel S, Ginn S, Greer S (1982) Intraarterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 50:850–862
Cohen AM, Kaufman SD, Wood WC, Greenfield AJ (1983) Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg 145:529–533
Balch CM, Urist MM, Soong SJ, McGregor M (1983) A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198:567–573
Balch CM, Urist MM (1986) Intraarterial chemotherapy for colorectal liver metastases and hepatomas using a totally implantable drug infusion pump. In: Recent Results Cancer Res 100:234–247
Daly JM, Kemeny N, Oderman P, Botet J (1984) Long-term hepatic arterial infusion chemotherapy: anatomic considerations, operative technique and treatment morbidity. Arch Surg 119:936–941
Shepard KV, Levin B, Karl RC, Faintuch J, DuBrow RA, Hagle M et al. (1985) Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using subcutaneous implanted pump. J Clin Oncol 3:161–169
Kemeny N, Reichman B, Oderman P, Daly J, Geller N (1986) Update of randomized study of intrahepatic (H) vs systemic (S) infusion of fluorodeoxyuridine (FUDR) in patients with liver metastases from colorectal carcinoma (CRC). Proc Am Soc Clin Oncol 5:47
Patt YZ, Boddie AW, Charnsangavej C, Ajani JA, Wallace S, Soski M et al. (1986) Hepatic arterial infusion with fluoxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer. J Clin Oncol 4:1356–1364
Hottenrott C, Lorenz M (1987) Stellenwert der regionalen Chemotherapie der Leber. Z Gastroenterol 25:364–373
Wagner JS, Adson MA, van Heerden JA, Adson MH, Ilstrup DM (1984) The natural history of hepatic metastases from celorectal cancer. A comparison with resective treatment Ann Surg 199:502–508
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bittner, R., Safi, F., Link, K.H., Beger, H.G. (1990). Current Standards and Limits in Treatment of Hepatic Metastases. In: Jakesz, R., Rainer, H. (eds) Progress in Regional Cancer Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74818-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-74818-9_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74820-2
Online ISBN: 978-3-642-74818-9
eBook Packages: Springer Book Archive